INEYE THERAPEUTICS S.A.

INEYE THERAPEUTICS S.A.

Private
CoimbraHealthcare & Life Scienceshttps://ineyetherapeutics.com/

Last Round

VC Round

Jul 2, 2025

Total Funding Raised

$190,000

Momentum Score

50 /100

Company Overview

INEYE THERAPEUTICS S.A. is a biotechnology company developing a patented ocular drug delivery technology for the treatment of eye diseases such as dry eye syndrome.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share

AI Layer

Non-AI

Keywords

ocular drug deliverysustained drug releaseocular insertdrug-device combinationglaucoma treatmentdry eye treatmenteye drops replacementophthalmologypost-cataract surgerymedtechbiotechpolymeric insertclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

INEYE THERAPEUTICS S.A. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

INEYE THERAPEUTICS S.A. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 2, 2025
GrantMar 20, 2025
SeedSep 18, 2023

Key People

Founding team and executive leadership

Paula Ferreira

CTO & Co-Founder, Co-Founder

Founding Team

Marcos M.

CEO

Executive Team

INEYE THERAPEUTICS S.A. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Monthly visitors grew 7117% MoM, from 6 to 433.

  • Jul 2, 2025

    $710K round with Portugal Ventures and Insight Venture.

INEYE THERAPEUTICS S.A. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

INEYE THERAPEUTICS S.A. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about INEYE THERAPEUTICS S.A.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCoimbra
Employee Range7
Year Founded2017
Last FundingJul 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.